These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12438252)

  • 1. Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells.
    Bateman AR; Harrington KJ; Kottke T; Ahmed A; Melcher AA; Gough MJ; Linardakis E; Riddle D; Dietz A; Lohse CM; Strome S; Peterson T; Simari R; Vile RG
    Cancer Res; 2002 Nov; 62(22):6566-78. PubMed ID: 12438252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy.
    Higuchi H; Bronk SF; Bateman A; Harrington K; Vile RG; Gores GJ
    Cancer Res; 2000 Nov; 60(22):6396-402. PubMed ID: 11103804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth.
    Bateman A; Bullough F; Murphy S; Emiliusen L; Lavillette D; Cosset FL; Cattaneo R; Russell SJ; Vile RG
    Cancer Res; 2000 Mar; 60(6):1492-7. PubMed ID: 10749110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion.
    Linardakis E; Bateman A; Phan V; Ahmed A; Gough M; Olivier K; Kennedy R; Errington F; Harrington KJ; Melcher A; Vile R
    Cancer Res; 2002 Oct; 62(19):5495-504. PubMed ID: 12359759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming.
    Errington F; Jones J; Merrick A; Bateman A; Harrington K; Gough M; O'Donnell D; Selby P; Vile R; Melcher A
    Gene Ther; 2006 Jan; 13(2):138-49. PubMed ID: 16136162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.
    Errington F; Bateman A; Kottke T; Thompson J; Harrington K; Merrick A; Hatfield P; Selby P; Vile R; Melcher A
    Clin Cancer Res; 2006 Feb; 12(4):1333-41. PubMed ID: 16489091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer.
    Lin EH; Salon C; Brambilla E; Lavillette D; Szecsi J; Cosset FL; Coll JL
    Cancer Gene Ther; 2010 Apr; 17(4):256-65. PubMed ID: 19893593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide sensitizes tumor cells to dendritic cell-mediated apoptosis, uptake, and cross-presentation.
    Huang J; Tatsumi T; Pizzoferrato E; Vujanovic N; Storkus WJ
    Cancer Res; 2005 Sep; 65(18):8461-70. PubMed ID: 16166326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
    Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
    J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction.
    Johnson KJ; Peng KW; Allen C; Russell SJ; Galanis E
    Gene Ther; 2003 May; 10(9):725-32. PubMed ID: 12704411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient CTL productivity of modified fusion cells by increase of heat shock protein 70.
    Koide T; Iinuma H; Fukushima R
    Oncol Rep; 2009 Mar; 21(3):737-46. PubMed ID: 19212634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent tumor-specific immunity induced by an in vivo heat shock protein-suicide gene-based tumor vaccine.
    Ren W; Strube R; Zhang X; Chen SY; Huang XF
    Cancer Res; 2004 Sep; 64(18):6645-51. PubMed ID: 15374979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
    Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
    Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loading.
    Larmonier N; Mérino D; Nicolas A; Cathelin D; Besson A; Bateman A; Solary E; Martin F; Katsanis E; Bonnotte B
    Apoptosis; 2006 Sep; 11(9):1513-24. PubMed ID: 16738802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.
    Wolfers J; Lozier A; Raposo G; Regnault A; Théry C; Masurier C; Flament C; Pouzieux S; Faure F; Tursz T; Angevin E; Amigorena S; Zitvogel L
    Nat Med; 2001 Mar; 7(3):297-303. PubMed ID: 11231627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S; Hara E; Homma S; Torii A; Toyama Y; Kawahara H; Watanabe M; Yanaga K; Fujise K; Tajiri H; Gong J; Toda G
    Clin Cancer Res; 2005 Nov; 11(21):7891-900. PubMed ID: 16278414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12.
    Okada N; Iiyama S; Okada Y; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T; Fujita T; Yamamoto A
    Cancer Gene Ther; 2005 Jan; 12(1):72-83. PubMed ID: 15389286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of NF-kappaB in fusogenic membrane glycoprotein causing HL-60 cell death: implications for acute myeloid leukemia.
    Tan L; Jia H; Liu R; Wu J; Han H; Zuo Y; Yang S; Huang W
    Cancer Lett; 2009 Jan; 273(1):114-21. PubMed ID: 18783878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of dendritic cell-based vaccine potency by anti-apoptotic siRNAs targeting key pro-apoptotic proteins in cytotoxic CD8(+) T cell-mediated cell death.
    Kim JH; Kang TH; Noh KH; Bae HC; Kim SH; Yoo YD; Seong SY; Kim TW
    Immunol Lett; 2009 Jan; 122(1):58-67. PubMed ID: 19135479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.